Drug Safety Information for THYROLAR-0.25 (Liotrix (t4;t3))

Adverse Drug Reactions for THYROLAR-0.25* (Liotrix (t4;t3))

These charts and graphs are based on reports received through the FDA Adverse Event Reporting System (FAERS) program (see below).

Top 20 Adverse Effects Associated with THYROLAR-0.25
(reported in FDA Medwatch/FAERS Reports)

  Side Effect # of FDA Reports
1Insomnia10
2Fatigue9
3Hypertension8
4Pneumonia7
5Diarrhoea7
6Loss of consciousness7
7Pyrexia7
8Condition aggravated6
9Weight increased6
10Pain in extremity6
11Pleural effusion6
12Dyspnoea6
13Drug interaction6
14Dizziness6
15Pain5
16Renal failure5
17Tremor5
18Cataract5
19Blood pressure increased5
20Atrial fibrillation5

* This side effect also appears in "Top 10 Side Effects of THYROLAR-0.25 " in the drug's Review Summary based on AskaPatient reviews.

Top 10 Reasons for Taking THYROLAR-0.25
(associated with FDA Medwatch/FAERS Reports)

Reason # of FDA Reports
1Hypothyroidism232
2Product used for unknown indication27
3Thyroid disorder26
4Hyperthyroidism13
5Thyroid neoplasm13
6Thyroidectomy9
7Post procedural hypothyroidism7
8Hypercholesterolaemia3

*Also a top-10 reason in AskaPatient Review Summary.


Types of Adverse Events for THYROLAR-0.25

Total Reports Filed with FDA: 712


Number of FDA Adverse Event Reports by Patient Age for THYROLAR-0.25

Total Reports Filed with FDA: 712*


* Reports for drugs with the same active ingredients have been aggregated in this analysis: Liotrix (t4;t3) (Euthroid-3, Euthroid-2, Thyrolar-5, Euthroid-0.5, Thyreotom, Thyrolar-0.25, Thyrolar-0.5, Thyrolar-2, Thyrolar-1, Thyrolar-3, Euthyral, Euthroid, Euthroid-1)

Charts are based on 712 reports filed with the FDA between 2004 and June 2015.

Adverse Event Reports are submitted to the FDA by pharmaceutical companies (mandatory reporting is required by manufacturers, distributors, or importers), health care providers such as doctors (voluntary reporting), and by patients themselves (voluntary reporting). More Information on FDA MedWatch (FDA Safety Information and Adverse Event Reporting Program)Voluntary reporting takes place under the FDA's MedWatch program, where health care professionals and consumers submit reports to FDA when they find a problem with a drug, medical device, biologic, or other FDA-regulated product. An adverse event is any undesirable experience or extreme side effect associated with the use of a medical product. Adverse events include: death, life threatening event, hospitalization, disability or permanent damage, congenital anomaly or birth defect, medical product use requiring a surgical or other intervention, or other serious medical situation believed to be caused by the drug.

Click to go back to search results and THYROLAR-0.25 Reviews and Review Summary .

Analytics of FDA Adverse Event Reports Provided by Druginformer.com. FDA Drug Safety Information, including safety-related labeling updates, required post-approval safety studies, risk evaluation management strategies (REMS), alerts, and recalls are compiled by AskaPatient.com from the U.S. Food and Drug Administration.

Visit   DrugInformer.com more on THYROLAR-0.25's side effects.